SCRS Welcomes Vertex as a New Global Impact Partner
Contact:
Mary D’Rozario
Director of Communications
Society for Clinical Research Sites
919.890.5513
mary.drozario@myscrs.org
FOR IMMEDIATE RELEASE
SCRS Welcomes Vertex as a New Global Impact Partner
Ellicott City, MD, May 9, 2017 – The Society for Clinical Research Sites (SCRS) announced today that Vertex is a new Global Impact Partner (GIP). Through this partnership, Vertex will serve on the SCRS Global Impact Board and work closely with the organization’s Leadership Council on setting and working toward strategic initiatives.
“The GIP program at SCRS fosters communication between key industry stakeholders and sites,” said Christine Pierre, president of SCRS. “Seeing pharmaceutical companies at various sizes and stages of commercialization become GIPs highlights the value SCRS provides.”
###
About Vertex
Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. In addition to our clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases. Founded in 1989 in Cambridge, Mass., Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. For seven years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences. For additional information and the latest updates from the company, please visit www.vrtx.com.
About SCRS
SCRS is a global trade organization founded in 2012 which represents over 4,000 research sites in 4754 countries. SCRS’ mission is to unify the voice of the global clinical research site community for greater site sustainability. SCRS has become an active partner in industry-wide initiatives and dialogues focused on improving the clinical research enterprise. Sites and the companies that sponsor or support the work conducted at clinical research sites will benefit from membership and partnership. Visit MySCRS.org.
